|
US5744500A
(en)
*
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
JP2004537506A
(ja)
|
2001-03-01 |
2004-12-16 |
ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド |
血液細胞欠乏症を治療するためのある種のステロイドの使用
|
|
JP2006506445A
(ja)
|
2002-08-28 |
2006-02-23 |
ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド |
治療処置の方法
|
|
EP1565185A4
(en)
*
|
2002-11-07 |
2011-01-05 |
Technion Res & Dev Foundation |
NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH
|
|
US7396860B2
(en)
|
2002-11-15 |
2008-07-08 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
WO2005051371A1
(en)
|
2003-11-25 |
2005-06-09 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treatment of cardiovascular disorders and diseases
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
AU2005269416B2
(en)
*
|
2004-07-26 |
2011-07-28 |
Teva Pharmaceutical Industries, Ltd. |
Pharmaceutical dosage forms including rasagiline
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
EP1807118B8
(en)
|
2004-09-29 |
2014-04-23 |
Harbor Therapeutics, Inc. |
Steroid analogs and characterization and treatment methods
|
|
WO2006089164A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Teva Pharmaceutical Industries, Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
CA2600011C
(en)
|
2005-02-23 |
2015-11-10 |
Teva Pharmaceutical Industries Ltd. |
Rasagiline formulations of improved content uniformity
|
|
US8263655B2
(en)
*
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
CA2630037C
(en)
*
|
2005-11-17 |
2015-03-31 |
Teva Pharmaceutical Industries Ltd. |
Methods for isolating propargylated aminoindans
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
JP2009518433A
(ja)
*
|
2005-12-09 |
2009-05-07 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム |
神経保護用の低用量ラドスチギルの使用
|
|
US8809310B2
(en)
|
2006-02-21 |
2014-08-19 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of multiple system atrophy
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
WO2007117431A2
(en)
|
2006-04-03 |
2007-10-18 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of restless legs syndrome
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
ZA200903904B
(en)
*
|
2006-12-14 |
2010-08-25 |
Teva Pharma |
Tannate salt of rasagiline
|
|
CN101557706B
(zh)
*
|
2006-12-14 |
2013-08-07 |
泰华制药工业有限公司 |
雷沙吉兰碱结晶固体
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
JP2010538067A
(ja)
*
|
2007-09-05 |
2010-12-09 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンを使用する緑内障の治療方法
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
CA2711817A1
(en)
*
|
2008-01-11 |
2009-07-16 |
Teva Pharmaceutical Industries Ltd. |
Rasagiline formulations, their preparation and use
|
|
US20110027354A1
(en)
*
|
2008-04-01 |
2011-02-03 |
Kim Hyoung-Chun |
Anti-parkinsonian compounds
|
|
WO2009151594A1
(en)
*
|
2008-06-10 |
2009-12-17 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline soft gelatin capsules
|
|
US20090312436A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Ruth Levy |
Rasagiline for parkinson's disease modification
|
|
AU2009260733B2
(en)
*
|
2008-06-19 |
2015-01-29 |
Teva Pharmaceutical Industries, Ltd. |
Process for purifying rasagiline base
|
|
JP2011524907A
(ja)
|
2008-06-19 |
2011-09-08 |
テバ ファーマシューティカル インダストリーズ リミティド |
固体ラサギリン塩基を調製および乾燥する方法
|
|
US8080584B2
(en)
*
|
2009-01-23 |
2011-12-20 |
Teva Pharmaceuticals Industries, Ltd. |
Delayed release rasagiline citrate formulation
|
|
PT2451771E
(pt)
|
2009-07-09 |
2014-09-19 |
Ratiopharm Gmbh |
Sais de rasagilina e suas preparações farmacêuticas
|
|
NZ602111A
(en)
|
2010-02-03 |
2014-10-31 |
Pharma Two B Ltd |
Extended release formulations of rasagiline and uses thereof
|
|
EP2598136A4
(en)
|
2010-07-27 |
2015-03-25 |
Teva Pharma |
DISPERSIONS OF RASAGILINE CITRATE
|
|
RU2587330C2
(ru)
|
2010-07-27 |
2016-06-20 |
Тева Фармасьютикал Индастриз Лтд. |
Применение разагилина для лечения обонятельной дисфункции
|
|
EA201490760A1
(ru)
|
2011-10-10 |
2014-09-30 |
Тева Фармасьютикал Индастриз Лтд. |
R(+)-n-метилпропаргиламиноиндан
|
|
EA201490761A1
(ru)
|
2011-10-10 |
2014-11-28 |
Тева Фармасьютикал Индастриз Лтд. |
R(+)-n-формилпропаргиламиноиндан
|
|
AR092168A1
(es)
|
2012-08-17 |
2015-03-25 |
Teva Pharma |
Formulaciones parenterales de rasagilina
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|